Author

Harri K. Mustonen

University of HelsinkiORCID 0000-0001-5632-6796Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pathology· 2 Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alli Leppä· 2 shared Arto KokkolaiD· 2 shared Caj Haglund· 2 shared Camilla BöckelmaniD· 2 shared Jefim BrodkiniD· 2 shared Marko SalmiiD· 2 shared Markus J. V. Vähä-KoskelaiD· 2 shared Sirpa JalkaneniD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Alli Leppä

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

PathologyOncologyPeer-reviewedSep 4, 2026

CCL5, CLEC11A, IL-7, IL-8, and IL-13: Diagnostic serum biomarkers of gastric cancer identified in a 48-multiplex panel

Jefim Brodkin, Tuomas Kaprio, Harri K. Mustonen…·Camilla Böckelman

The paper identifies five serum biomarkers for gastric cancer using a 48-plex panel in a cohort of 239 patients and 48 controls.

DOI 10.1159/ocl/aebag009

humanproteomics

𝕏 PostBluesky

BioinformaticsbioRxivPreprintMay 10, 2026

Predicting Pre-treatment Resistance or Post-treatment Effect? A Systematic Benchmarking of Single-Cell Drug Response Models

Li Shen, Xinliang Sun, Shuyu Zheng…·Jing Tang

This study benchmarks single-cell drug response models across 26 datasets, showing performance varies with dataset type, imbalance, and model design, with scDEAL showing competitive results.

DOI 10.64898/2026.04.10.717709

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 4, 2025

Therapeutic Eradication of Cancer-associated Fibroblasts Inhibits in vivo progression of Pancreatic Cancer

Matilda Roos-Mattila, Harri K. Mustonen, Markus J. V. Vähä-Koskela…·Hanna E. Seppänen

This study shows that clemastine eradicates cancer-associated fibroblasts, halts pancreatic cancer progression, and synergizes with gemcitabine to inhibit metastasis.

DOI 10.1101/2025.11.04.686484

mouseorganoid / primary culture

𝕏 PostBluesky

PathologybioRxivPreprintAug 17, 2025

CXCL12, SCF, and eotaxin are prognostic serum biomarkers in gastric cancer

Jefim Brodkin, Tuomas Kaprio, Harri K. Mustonen…·Camilla Böckelman

The paper identifies CXCL12, SCF, and eotaxin as prognostic serum biomarkers for gastric cancer using univariate and multivariate survival analysis.

DOI 10.1101/2025.08.17.670705

humanproteomics

𝕏 PostBluesky